{
  "authors": [
    {
      "author": "Elena Campione"
    },
    {
      "author": "Annunziata Dattola"
    },
    {
      "author": "Monia Di Prete"
    },
    {
      "author": "Daniele Di Paolo"
    },
    {
      "author": "Amedeo Ferlosio"
    },
    {
      "author": "Augusto Orlandi"
    },
    {
      "author": "Luca Bianchi"
    }
  ],
  "doi": "10.1186/s12895-019-0086-4",
  "publication_date": "2019-05-18",
  "id": "EN112294",
  "url": "https://pubmed.ncbi.nlm.nih.gov/31096980",
  "source": "BMC dermatology",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "A 53-year-old Caucasian man with a history of hepatitis C virus genotype 1 infection was examined at our Department of Dermatology for the occurrence of palpable purpura. The patient referred that the first appearance of the dermatoses was about one month after initiation of therapy with Sofosbuvir for hepatitis C."
}